Tag: Cells

Search News
Categories
Archives
Professor Sarah McClelland awarded £1.5m from CRUK to study cancer’s chromosomal chaos

25th November 2024

Congratulations to Professor Sarah McClelland, who has received a £1,500,000 Programme Foundation Award from Cancer Research UK (CRUK), to support her lab’s work at Barts Cancer Institute (BCI), Queen Mary University of London.

Read more

New study suggests promising approach for treating pancreatic cancer

18th October 2023

Researchers have pinpointed the cells that drive the spread of pancreatic cancer and revealed a weakness in these cells that could be targeted using existing cancer drugs.

Read more

How cancer cells shapeshift to spread through the body

23rd August 2023

Researchers show how cancer cells rearrange their inner workings to squeeze between obstacles

Read more

BCI researcher receives prestigious MRC grant to investigate how HPV infection develops into cancer

27th May 2022

Dr Sarah McClelland from BCI is part of a collaborative project that has secured £1.2 million in funding from the Medical Research Council to investigate the mechanisms leading to cancer development in cells infected with human papillomavirus.

Read more

Cancer cell communications

12th March 2021

We spoke with Dr Susana Godinho, Group Leader in Barts Cancer Institute’s Centre for Cancer Cell and Molecular Biology, to find out about her recent paper published in Current Biology. Dr Godinho and her team set out to identify why cancer cells carrying extra centrosomes exhibit increased release of communications packages known as small extracellular vesicles.

Read more

Chromosomal instability in ovarian cancer

26th November 2020

We spoke with Dr Sarah McClelland and senior postdoctoral researcher in her group, Dr Nadeem Shaikh, about the team’s most recent paper, published in Cancer Research, which set out to explore the mechanisms of chromosomal instability in high-grade serous ovarian carcinoma – the most common type of ovarian cancer. The study sheds light on how these mechanisms may be able to be targeted to overcome treatment resistance in this cancer type.

Read more

Search News
Categories
Archives